Mayar Capital Ltd. Laboratory Corp Of America Holdings Transaction History

Mayar Capital Ltd.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	SELL	$192.5 - $216.35 $86,047 - $96,708	-447 Reduced 2.22%	19,672 $4 Million
Q1 2024 May 03, 2024	SELL	$209.01 - $232.56 $632,673 - $703,959	-3,027 Reduced 13.08%	20,119 $4.4 Million
Q1 2023 Apr 25, 2023	SELL	$213.32 - $257.83 $2.66 Million - $3.22 Million	-12,480 Reduced 35.03%	23,146 $5.31 Million
Q4 2022 Jan 20, 2023	SELL	$203.72 - $248.97 $691,833 - $845,502	-3,396 Reduced 8.7%	35,626 $8.39 Million
Q3 2022 Oct 18, 2022	BUY	$204.81 - $262.19 $245,567 - $314,365	1,199 Added 3.17%	39,022 $7.99 Million
Q2 2022 Jul 26, 2022	BUY	$213.86 - $277.87 $1.32 Million - $1.72 Million	6,173 Added 19.5%	37,823 $8.86 Million
Q1 2022 Apr 21, 2022	BUY	$259.82 - $298.18 $237,995 - $273,132	916 Added 2.98%	31,650 $8.35 Million
Q4 2021 Jan 28, 2022	SELL	$271.6 - $314.21 $1.76 Million - $2.04 Million	-6,482 Reduced 17.42%	30,734 $9.66 Million
Q3 2021 Nov 02, 2021	SELL	$274.82 - $308.34 $1.94 Million - $2.18 Million	-7,075 Reduced 15.97%	37,216 $10.5 Million
Q2 2021 Jul 23, 2021	SELL	$251.87 - $278.14 $152,885 - $168,830	-607 Reduced 1.35%	44,291 $12.2 Million
Q1 2021 Apr 26, 2021	BUY	$204.88 - $255.03 $9.2 Million - $11.5 Million	44,898 New	44,898 $11.5 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Mayar Capital Ltd., based on Form 13F filings with the SEC.

Stay updated on Mayar Capital Ltd. with notifications on news.